Prime Capital Investment Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $468K | Sell |
1,203
-281
| -19% | -$109K | 0.01% | 634 |
|
|
2025
Q1 | $646K | Buy |
1,484
+464
| +45% | +$202K | 0.01% | 600 |
|
|
2024
Q4 | $376K | Sell |
1,020
-294
| -22% | -$109K | 0.01% | 653 |
|
|
2024
Q3 | $683K | Sell |
1,314
-156
| -11% | -$81.1K | 0.01% | 518 |
|
|
2024
Q2 | $797K | Buy |
1,470
+26
| +2% | +$14.1K | 0.01% | 478 |
|
|
2024
Q1 | $749K | Sell |
1,444
-203
| -12% | -$105K | 0.01% | 520 |
|
|
2023
Q4 | $777K | Buy |
1,647
+547
| +50% | +$258K | 0.01% | 477 |
|
|
2023
Q3 | $479K | Sell |
1,100
-53
| -5% | -$23.1K | 0.01% | 478 |
|
|
2023
Q2 | $512K | Buy |
1,153
+119
| +12% | +$52.9K | 0.01% | 472 |
|
|
2023
Q1 | $476K | Buy |
1,034
+229
| +28% | +$105K | 0.02% | 351 |
|
|
2022
Q4 | $413K | Buy |
805
+98
| +14% | +$50.3K | 0.02% | 360 |
|
|
2022
Q3 | $321K | Buy |
707
+216
| +44% | +$98.1K | 0.02% | 296 |
|
|
2022
Q2 | $237K | Buy |
+491
| New | +$237K | 0.01% | 329 |
|
|
2020
Q3 | – | Sell |
-154
| Closed | -$40K | – | 462 |
|
|
2020
Q2 | $40K | Buy |
154
+7
| +5% | +$1.82K | ﹤0.01% | 337 |
|
|
2020
Q1 | $33K | Sell |
147
-28
| -16% | -$6.29K | ﹤0.01% | 312 |
|
|
2019
Q4 | $53K | Sell |
175
-57
| -25% | -$17.3K | 0.01% | 303 |
|
|
2019
Q3 | $56K | Buy |
+232
| New | +$56K | 0.01% | 290 |
|
|
2019
Q1 | – | Sell |
-105
| Closed | -$28K | – | 346 |
|
|
2018
Q4 | $28K | Buy |
+105
| New | +$28K | 0.01% | 187 |
|